Rigel Pharmaceuticals has completed its previously announced licensing agreement with [...]

Faeth Therapeutics has launched as a publicly traded oncology company [...]

Sensei Biotherapeutics has acquired Faeth Therapeutics and announced a concurrent [...]

Breast cancer remained the world’s most studied disease for the [...]

SpotitEarly, a US-based early cancer detection startup, has announced a [...]

VIVES Partners, managing company of VIVES Funds, has joined a [...]

The former ASCO president shares his insights on breast cancer [...]